Cross Country Healthcare, Inc. (NASDAQ: CCRN) had its price target lowered by analysts at Barrington Research from $24.00 to $21.00. They now have an "outperform" rating on the stock.
Cross Country Healthcare to Attend Benchmark’s Healthcare House Call Investor Conference
Cross Country Healthcare First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]
Cross Country Healthcare, Inc. (NASDAQ: CCRN) had its price target lowered by analysts at Benchmark Co. from $21.00 to $19.00. They now have a "buy" rating on the stock.
Cross Country Healthcare, Inc. (NASDAQ:CCRN) Q1 2024 Earnings Call Transcript [Yahoo! Finance]